Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor

Background: The increasing incidence of ischemic stroke has led to the search for a novel biomarker to predict the course of disease and the risk of mortality. Recently, the role of the soluble urokinase plasminogen activator receptor (suPAR) as a biomarker and indicator of immune system activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Śmiłowska, Katarzyna, Śmiłowski, Marek, Partyka, Robert, Kokocińska, Danuta, Jałowiecki, Przemysław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953259/
https://www.ncbi.nlm.nih.gov/pubmed/35330458
http://dx.doi.org/10.3390/jpm12030457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953259/
https://www.ncbi.nlm.nih.gov/pubmed/35330458
http://dx.doi.org/10.3390/jpm12030457

Ejemplares similares